![](/img/cover-not-exists.png)
Safety and Immunogenicity of the GamTBvac, the Recombinant Subunit Tuberculosis Vaccine Candidate: A Phase II, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study
Tkachuk, Artem P., Bykonia, Evgeniia N., Popova, Liubov I., Kleymenov, Denis A., Semashko, Maria A., Chulanov, Vladimir P., Fitilev, Sergey B., Maksimov, Semyon L., Smolyarchuk, Elena A., Manuylov, ViVolume:
8
Journal:
Vaccines
DOI:
10.3390/vaccines8040652
Date:
November, 2020
File:
PDF, 13.75 MB
2020